Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2010
08/25/2010CN101812190A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same
08/25/2010CN101812189A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same
08/25/2010CN101810861A Liquid preparation for preventing and curing mucous membrane and skin inflammation
08/25/2010CN101810859A Medical composition containing aniline derivative
08/25/2010CN101810823A Chinese medicinal composition for treating renal cyst diseases and preparation method thereof
08/25/2010CN101810811A Formula of orally-taken Chinese medicament for treating chylous urine
08/25/2010CN101810803A Chinese medicinal composition for treating hematuria and preparation method thereof
08/25/2010CN101810796A Medicament for treating nephritic syndromes
08/25/2010CN101810792A Chinese medicinal composition for treating kidney failure diseases and preparation method thereof
08/25/2010CN101810790A Chinese medicinal preparation for curing ureteral calculi
08/25/2010CN101810788A Chinese medicinal preparation for curing cystitis
08/25/2010CN101810757A Plaster for treating benign prostatic hyperplasia
08/25/2010CN101810752A Method for detecting quality of Chinese medicament for treating prostatitis
08/25/2010CN101810749A Chinese medicament for treating urinary tract infection
08/25/2010CN101810748A Formula of orally-taken Chinese medicament for treating chronic prostatitis
08/25/2010CN101810727A Chinese medicament for treating various painful diseases and preparation method thereof
08/25/2010CN101810711A Chinese medicinal preparation for curing hepatorenal syndrome
08/25/2010CN101810688A Chinese medicinal composition for treating urinary disease and preparation method thereof
08/25/2010CN101810678A Chinese medicinal composition for treating urinary calculi of livestock and poultry and preparation method thereof
08/25/2010CN101810637A Heparin-derived polysaccharide mixtures, preparation thereof and pharmaceutical compositions containing same
08/25/2010CN101810565A Tolterodine gel preparation and preparation method thereof
08/25/2010CN101224279B Medicine compound for treating urinary infection and preparing method thereof
08/25/2010CN101167970B Method for preparing gastrodia tuber dispensing granule
08/25/2010CN101084944B Composition for prophylaxis or treatment of urinary system infection
08/25/2010CN101065119B Ameliorant for renal insufficiency
08/25/2010CN101040879B Method for detecting the quality of pine pollen fingerprinting in the resistance-strengthening and stasis-dispersing plant medicine
08/24/2010US7781596 Substituted 2-phenylbenzimidazoles, the production thereof and their use
08/24/2010US7781584 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
08/24/2010US7781455 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; dipeptidylpeptidase-IV enzyme inhibitors; diabetes
08/24/2010CA2462510C Wipe formulation
08/19/2010WO2010092966A1 Novel triazine derivative and pharmaceutical composition containing same
08/19/2010WO2010075263A3 Compounds and methods for enhancing erythropoiesis
08/19/2010WO2010066028A8 3,4 - substituted piperidine derivatives as renin inhibitors
08/19/2010WO2010056472A3 Compositions and methods of use for soluble thrombomodulin variants
08/19/2010WO2010054397A3 N-cadherin: target for cancer diagnosis and therapy
08/19/2010WO2009135581A3 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
08/19/2010US20100210838 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
08/19/2010US20100210690 N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210678 Tricyclic androgen receptor modulator compounds and methods
08/19/2010US20100210668 Composition and method for treatment or prevention of benign prostatic hyperplasia and lower urinary tract symptoms
08/19/2010US20100210643 sGC STIMULATORS, sGC ACTIVATORS AND COMBINATIONS FOR THE TREATMENT OF UROLOGICAL DISORDERS
08/19/2010US20100210641 Organic Compounds
08/19/2010US20100210637 Heteroaryloxy nitrogenous saturated heterocyclic derivative
08/19/2010US20100210635 Renin inhibitors
08/19/2010US20100210633 Carboxamide compounds and their use
08/19/2010US20100210593 Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators
08/19/2010US20100210559 Trap-14 as a therapeutic agent
08/19/2010US20100210555 Use of a laminin peptide as a therapeutic agent
08/19/2010US20100210552 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions
08/19/2010US20100210514 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210513 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210476 Pyrrolo[2,3-b]Pyridine Derivatives Active as Kinase Inhibitors and Pharmaceutical Compositions Comprising Them
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209513 Pharmaceutical composition containing micronized particles of naphthoquinone-based compound
08/19/2010US20100209506 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
08/19/2010US20100209480 Galenical formulations of organic compounds
08/19/2010US20100209408 Remodeling of Tissues and Organs
08/19/2010DE202009008263U1 Zusammensetzung zur Behandlung entzündlicher Erkrankungen Composition for the treatment of inflammatory diseases
08/19/2010DE102009000854A1 Osteopontin-receptor-ligand for binding osteopontin receptors of podocytes of the renal corpuscles, useful for treating chronic renal failure
08/19/2010CA2752269A1 Novel triazine derivative and pharmaceutical composition comprising the same
08/18/2010EP2218735A1 Diagnostic and therapeutic use of Kremen 1 and 2, inhibitors of the canonical Wnt-signaltransduction
08/18/2010EP2218732A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218731A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218730A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
08/18/2010EP2218718A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
08/18/2010EP2217238A2 Methods and compositions for the treatment of proteinuric diseases
08/18/2010EP1767633B1 Novel polypeptide useful for diagnosis and treatment of cancer
08/18/2010CN1704121B Anti-angiogenic compositions and methods of use
08/18/2010CN101808632A Controlled release tamsulosin hydrochloride tablets and a process of making them
08/18/2010CN101805349A Furan-azo- [3,2-g] chromene compound and application thereof
08/18/2010CN101804181A Traditional Chinese medicine preparation for treating prostatitis and preparation method thereof
08/18/2010CN101804176A Traditional Chinese medicine preparation for treating chyluria
08/18/2010CN101804169A Traditional Chinese medicine composition for treating urinary incontinence and preparation method thereof
08/18/2010CN101804165A Preparation for clearing nephrotoxicity, strengthening internal organs, enhancing physique and preventing aging and preparation method thereof
08/18/2010CN101804143A Traditional Chinese medicine composition for treating urinary tract infection of perimenopausal women
08/18/2010CN101804126A Application of traditional Chinese medicine composition in treating qi-blood deficiency and spleen-kidney deficiency and preparation method thereof
08/18/2010CN101804090A Tablet used for treating prostate diseases as well as preparation method and application thereof
08/18/2010CN101548956B Sub-micro emulsion frozen preparation of aztreonam
08/18/2010CN101204495B Peroral Chinese traditional medicine composition for chronic nephritis
08/18/2010CN101199816B Medicament for anti-inflammation and analgesis
08/18/2010CN101199720B Chinese medicine compound for oral administration for treating chronicity nephritis
08/18/2010CN101129713B Medicine for treating prostatosis and method for preparing same
08/18/2010CN101088519B Tripterygium glycosides extract and its extraction process
08/17/2010US7777057 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7776921 Treating benign prostate hyperplasia with SARMS
08/17/2010US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis
08/17/2010US7776879 anticholinergic agents such as Butylthiophen-2-ylmethylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester, having a high affinity for muscarinic M3 receptors, useful for treating respiratory system, urogenital, gastrointestinal and cardiovascular disorders
08/17/2010US7776861 Cycloheteroalkenyl compounds used as analgesics and for treating incontinence, inflammatory bowel disease, Parkinson's disease, amyotrophic lateral sclerosis, dementia, epilepsy, retinopathy, pruritus, psychoses, Huntington's disease, headaches, vomiting, dyskinesia or as anxiolytics and antidepressants
08/17/2010US7776854 1,3-benzothiazol-2-yl(2-{[4-(morpholin-4-ylmethyl)benzyl]oxy}pyrimidin-4-yl)-acetonitrile; (or benzimidazole or benzoxazole 2-acetonitrile derivatives); systemic sclerosis, CREST, sine scleroderma, cirrhosis, heart failure; inhibitors of JNK (c-Jun N-terminal Kinases)
08/17/2010US7776369 lignan extract comprising a lignan complex including secoisolariciresinol diglucoside;wherein the lignan extract is substantially free of cyanogenic glycosides as determined by measuring free cyanides; use in treating cancer, diabetes, hypertension, lupus, and atherosclerosis
08/17/2010US7776354 Remedies for glomerular diseases
08/17/2010US7776319 Methods and compositions for treatment of ion imbalances
08/17/2010US7775469 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent
08/17/2010CA2458544C Crystals of hydroxynorephedrine derivative
08/17/2010CA2431974C Urea and urethane derivatives as integrin inhibitors
08/12/2010WO2010090850A1 Methods for treating or preventing radiocontrast agent induced kidney injury
08/12/2010WO2010090172A1 Pharmaceutical composition for oral administration
08/12/2010WO2010089119A1 Heterocyclic derivatives as m-glu5 antagonists
1 ... 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 ... 562